Renuka P. Limgala - Search Results

Year	Number of Results
2010	1
2016	4
2018	2
2019	1
2020	3
2021	1
2023	1
2024	0

1

Biofabrication of anin-vitrobone model for Gaucher disease.

Banerjee D, Ivanova MM, Celik N, Kim MH, Derman ID, Limgala RP, Ozbolat IT, Goker-Alpan O. Banerjee D, et al. Biofabrication. 2023 Sep 22;15(4):045023. doi: 10.1088/1758-5090/acf95a. Biofabrication. 2023. PMID: 37703870 Free PMC article.

2

Pregnancy Outcomes in Late Onset Pompe Disease.

Goker-Alpan O, Kasturi VG, Sohi MK, Limgala RP, Austin SL, Jennelle T, Banikazemi M, Kishnani PS. Goker-Alpan O, et al. Among authors: limgala rp. Life (Basel). 2020 Sep 11;10(9):194. doi: 10.3390/life10090194. Life (Basel). 2020. PMID: 32932790 Free PMC article.

3

Gaucheromas: When macrophages promote tumor formation and dissemination.

Ivanova M, Limgala RP, Changsila E, Kamath R, Ioanou C, Goker-Alpan O. Ivanova M, et al. Blood Cells Mol Dis. 2018 Feb;68:100-105. doi: 10.1016/j.bcmd.2016.10.018. Epub 2016 Oct 27. Blood Cells Mol Dis. 2018. PMID: 27839983 Clinical Trial.

4

Persistent immune alterations and comorbidities in splenectomized patients with Gaucher disease.

Sønder SU, Limgala RP, Ivanova MM, Ioanou C, Plassmeyer M, Marti GE, Alpan O, Goker-Alpan O. Sønder SU, et al. Blood Cells Mol Dis. 2016 Jul;59:8-15. doi: 10.1016/j.bcmd.2016.02.003. Epub 2016 Feb 15. Blood Cells Mol Dis. 2016. PMID: 27282561

5

Enzyme replacement therapy reverses B lymphocyte and dendritic cell dysregulations in patients with Gaucher Disease.

Limgala RP, Jani C, Ioanou C, Alpan O, Goker-Alpan O. Limgala RP, et al. Blood Cells Mol Dis. 2018 Feb;68:81-85. doi: 10.1016/j.bcmd.2016.10.015. Epub 2016 Oct 28. Blood Cells Mol Dis. 2018. PMID: 27839980 Clinical Trial.

6

Effect of Substrate Reduction Therapy in Comparison to Enzyme Replacement Therapy on Immune Aspects and Bone Involvement in Gaucher Disease.

Limgala RP, Goker-Alpan O. Limgala RP, et al. Biomolecules. 2020 Mar 31;10(4):526. doi: 10.3390/biom10040526. Biomolecules. 2020. PMID: 32244296 Free PMC article.

7

The Interaction of Innate and Adaptive Immunity and Stabilization of Mast Cell Activation in Management of Infusion Related Reactions in Patients with Fabry Disease.

Limgala RP, Fikry J, Veligatla V, Goker-Alpan O. Limgala RP, et al. Int J Mol Sci. 2020 Sep 29;21(19):7213. doi: 10.3390/ijms21197213. Int J Mol Sci. 2020. PMID: 33003611 Free PMC article.

8

Altered immune phenotypes in subjects with Fabry disease and responses to switching from agalsidase alfa to agalsidase beta.

Limgala RP, Jennelle T, Plassmeyer M, Boutin M, Lavoie P, Abaoui M, Auray-Blais C, Nedd K, Alpan O, Goker-Alpan O. Limgala RP, et al. Am J Transl Res. 2019 Mar 15;11(3):1683-1696. eCollection 2019. Am J Transl Res. 2019. PMID: 30972193 Free PMC article.

9

Selective screening for lysosomal storage disorders in a large cohort of minorities of African descent shows high prevalence rates and novel variants.

Limgala RP, Furtak V, Ivanova MM, Changsila E, Wilks F, Fidelia-Lambert MN, Goker-Alpan O, Gondré-Lewis MC. Limgala RP, et al. JIMD Rep. 2021 Jan 27;59(1):60-68. doi: 10.1002/jmd2.12201. eCollection 2021 May. JIMD Rep. 2021. PMID: 33977031 Free PMC article.

10

Efficient procurement of epithelial stem cells from human tissue specimens using a Rho-associated protein kinase inhibitor Y-27632.

Terunuma A, Limgala RP, Park CJ, Choudhary I, Vogel JC. Terunuma A, et al. Tissue Eng Part A. 2010 Apr;16(4):1363-8. doi: 10.1089/ten.TEA.2009.0339. Tissue Eng Part A. 2010. PMID: 19912046 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

11 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year